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GOALS AND AIMS   
This study serves to investigate the effect of peptide length, charge and charge density on each 
peptide’s ability to condense plasmid DNA. Several different peptides of varying physiochemical 
properties were tested for their ability to condense plasmid DNA for delivery to HUH7 hepatocytes 
using a lipid calcium phosphate (LCP) based delivery system [1].  Peptides were firstly tested for 
DNA nuclear import in vitro. Subsequently, three different peptides of varying properties were 
chosen to be tested in-vivo. Results demonstrated that that the crucial factor regarding the success 
of DNA delivery regards the balance between condensation and release of the peptide. Therefore, 
the most successful peptides are ones with a charge density that permits both condensation, and 
release  
 
INTRODUCTION AND BACKGROUND 
Previously, Hu et al. established a platform for the delivery of DNA to hepatocyte nuclei [2]. The 
platform, LCP, is a nanoparticle based delivery system consisting of a solid, calcium phosphate 
inner shell with a lipid bi-layer outer coating. Small aqueous droplets were formed in a much 
larger, oil phase emulsion through a water in oil micro emulsion. Within each aqueous droplet, a 
mixture of calcium chloride, ammonium phosphate and DNA/peptide complex precipitate to form 
a solid core. To encapsulate DNA, the DNA is firstly complexed with a peptide (CR8C) which 
serves to condense DNA, and act as a nuclear localization signal. Upon creation of the solid core, 
nanoparticles were then decorated with outer leaflet lipids, resembling a lipid bi-layer as seen on 
cell membranes [3].  These outer lipids can be functionalized to 1) evade clearance by the 
reticuloendothelial system and 2) prolong the circulation half life of the nanoparticles. 
Furthermore, the addition of targeting ligands such as galactose can 3) enhance organ/tissue 
specific delivery [4]. Nanoparticles can be administered intravenously in vivo for systemic 
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delivery. Once inside the nucleus, the encapsulated DNA was released from the delivery peptide 
before the nucleic acid can be transcribed and translated into a protein of interest [5]. The basic 
design of the LCP platform is shown below in Figure 1.  
 
Figure 1: Basic structure and design of LCP for the delivery of plasmid DNA. Notable features 
include the calcium phosphate core, the outer leaflet lipids, the functionalized ligands and the 
peptide nuclear localization signal. 
 
The rationale for delivering therapeutic plasmid DNA to hepatocyte nuclei is on the basis of gene 
therapy [6]. Specifically, the alteration of gene expression patterns in liver cancers can be a 
powerful tool in the prevention of eventual cancer metastasis and proliferation [7-9]. Yet, the 
delivery of therapeutic DNA in vivo has since been difficult as naked DNA is impossible to deliver; 
being rapidly degraded upon injection by DNase [10]. In light of this, the platform developed by 
Hu et al. presents a promising new option for the therapy of hepatic cancers. Furthermore, recent 
studies conducted by Goodwin et al. have reveled the possibility of preventing cancer metastasis 
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to the liver through the delivery of nucleic acids which prime the liver to resist becoming a cancer 
promoting niche [11].   
The success of this platform rests largely on the balance between the condensation and release of 
DNA from the peptide [12]. Specifically, the DNA must be bound to the delivery peptide tight 
enough to remain conjugated during delivery as the peptide serves as the nuclear localization 
signal. Conversely, the DNA must also be bound loose enough to release after successful nuclear 
entry. As a result, the delivery peptide plays a crucial role to the ultimate success or failure of the 
delivery platform. 
Perhaps the most crucial element of the system, the peptide nuclear localization signal, serves a 
dual function: to condense therapeutic DNA and act as the nuclear localization signal [13]. Despite 
its pivotal role however, the precise nature of how this delivery peptide affects nuclear 
delivery/import is largely unknown. Specifically, through which mechanism does the peptide 
import DNA? How do biochemical properties such as peptide length, charge and charge density 
affect both DNA condensation and release? Finally, could other condensation systems, such as 
histones, be used? 
Due to the multifaceted nature of the delivery system, this study firstly sought to determine the 
precise cellular mechanism for DNA import. It has long been speculated that the nuclear pore 
complex is responsible for importing delivered peptide conjugated DNA. However, this hypothesis 
has never been definitively proven. Therefore, this study will determine the precise cellular 
mechanism for DNA import. Subsequently, the ability of various peptides to deliver DNA into cell 
nuclei will be tested in vitro using fluorescently labeled DNA and confocal microscopy. Finally, 
three of peptides will be selected for testing in vivo to determine how the factors investigated above 
contribute to the overall success of DNA delivery in an animal model.  
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METHODS 
LCP Synthesis: Briefly 800 ug of luciferase or RFP plasmid DNA was mixed with 1800 uL 2.5 
mM CaCl2. For confocal imaging studies, approximately 40 ug of the 800 ug of DNA was either 
Cy3, or Cy5 labeled. In this study, we evaluated seven different peptides with various charges, 
lengths and charge densities. The peptides CR8C, CK8C, CR6C, CR4C, C(RG)4C, C(RG)2C, 
linear CR8C (l-CR8C) or histone H3 were added to the CaCl2 solution with the appropriate N:P 
ratio for each experiment. The aqueous mixture was immediately added to 60 mL of a solution 
composed of cyclohexane/igepal CO-520 (71:29, v/v) under vigorous stirring. To a separate flask, 
1800 uL of 50 mM (NH4)2HPO4 was added to another 60 mL of cyclohexane/igepal CO-520 
(71:29, v/v) under vigorous stirring. Both mixtures were allowed to stir at room temperature for 
20 minutes. Then, the mixtures were combined 1500 uL 25 mg/mL 1,2-dioleoyl-sn-glycero-3-
phosphate to generate the microemulsion. The emulsion was allowed to stir for 30 minutes at room 
temperature before 120 mL of 200 proof ethanol was added to disrupt the microemulsion. The 
nanoparticles were centrifuged and washed by ethanol three times before being dissolved in 1 mL 
DCM. Subsequently, 1875 uL, 1875 uL 2850 uL and 142.5 uL of 36 mM cholesterol, 25 mg/mL 
1-oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-3-trimethylammonium 
propane, 20 mM polyethylene glycol [2000] and 20 mM polyethylene glycol [2000] - Galactose, 
respectively, were added to the 1 mL of DCM. DCM was evaporated under vigorous stirring and 
nitrogen gas. The dried lipid film was re-suspended with 2.5 mL, 5% sucrose solution under 
sonication.  
DNA Amplification: DNA amplification was conducted following the established protocol 
provided by the Qiagen® Maxi-prep kit. In short, 5 ng of luciferase or RFP pDNA was transferred 
to 20 uL of DH5-alpha competent cells and heat shocked for 30 seconds in a 45ºC water bath. 
Subsequently, 950 uL of SOC media (Qiagen, Germany) was added to the competent cells. Cells 
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were stirred at 37 ºC overnight before being plated onto agar plates containing Kanamycin (1 
mg/mL) overnight. Colonies were then selected and cultured in 1 L of CircleGrow (MP 
Biomedical, USA) wt 1 mg/mL Kanamycin. Bacteria in culture media was then pelleted, 
resuspended and lysed to isolate plasmid DNA and purified in accordance to the protocol provided 
by Qiagen®. DNA concentrations were determined via UV spectroscopy and the 260/280 ratio 
confirms the quality of DNA if between 1.8 and 2.0.     
DNA Cy5/Cy3 Labeling: DNA labeling kits were purchased from Mirus Label IT ® (Mirus, USA). 
For each 5 ug of DNA to be labeled, 35 uL of molecular grade water, 5 uL of 10X labeling buffer 
A and 5 uL of Label IT ® reagent were added. The mixture was incubated at 37C or one hour. 
Subsequently, 0.1 volumes of 5 M sodium chloride and 2 volumes of cold ethanol were added to 
the reaction, mixed and stored at -20 C for 30 minutes. Subsequently, DNA was pelleted at 14,000 
x G centrifugation and reconstituted in 10 uL of sterile water. Using UV spectroscopy, it was 
observed that the approximate base/dye ratio was around 150 base pairs per florescent label.  
Imaging Procedure: HUH7 hepatocytes were cultured in RPMI growth media containing 10% 
FBS and 1% P/S antibiotic. Cultured cells were plated in a glass bottom imaging plate containing 
1 mL of growth media. Subsequently, 1 mL of resuspended particles was added dropwise to the 
cells under shaking. For testing of multiple peptides in the same dish, two separate nanoparticle 
formulations were added to cells, each formulation containing a different peptide/DNA complex. 
The cells and particles were allowed to incubate at 37ºC with 5% CO2 atmosphere for 1 hour. 
Subsequently, the media was removed, cells were washed once with PBS and 1 mL of new media 
was added to the cells. If importazole is to be used, 8 uL of importazole in DMSO was added at 
this point. Then, cells were imaged with a Zeiss 880 confocal microscope containing an imaging 
chamber that maintains at 37ºC with 5% CO2 atmosphere for the duration of imaging.  
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In Vivo Study: 40 ug of DNA-peptide complex in LCP NPs at a 2:1 N/P ratio was administered 
intravenously to BALB/c mice at a volume of 300 uL. As a positive control, 40 ug of DNA was 
administered directly to BALB/c mice using a hydrodynamic injection. For the hydrodynamic 
injection, the 40 ug of DNA was suspended in 1.2 mL of phosphate buffered saline. All 1.2 mL 
was injected IV at a rate of 1 mL per second. Mice were sacrificed 24 hours later via cervical 
dislocation. 
Tissue Processing: Mice were perfused with 20 mL of phosphate buffered saline prior to being 
sacrificed by cervical dislocation. Subsequently, the liver, kidney, spleen and lung were dissected 
and suspended in saline. Organs from each mouse were imaged on a Perkin Elmer IVIS imaging 
system. Subsequently, organs were fixed in 4% paraformaldehyde overnight before being 
suspended in 20% sucrose solution for an additional 24 hours. Then, organs were frozen in OTC 
tissue blocks in preparation for frozen sectioning. 8 micron sections were sliced, and stained with 
DAPI for visualization of cell nuclei.   
RESULTS AND DISCUSSION  
Nanoparticle Formulation  
The LCP nanoparticle (NP) platform was developed within our lab and has been modified to 
delivery a wide range of therapeutics [14, 15]. Some notable examples include chemotherapeutic 
drugs, siRNA, plasmid DNA and radiotracers [16-18]. The highly versatile LCP platform consists 
of a solid, calcium phosphate inner sphere (core) and an outer halo consisting of a lipid bilayer 
(outer leaflet lipid). The outer leaflet lipids typically contain, polyethylene glycol to evade RES 
uptake, cholesterol to stabilize the membrane, and some type of targeting ligand [19-21]. For the 
case of liver delivery, galactose was used herein for active targeting. To confirm the successful 
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formulation of LCP NP, transmission electron microscopy (TEM) images of nanoparticle cores 
were taken at 140,000X magnification. Data is shown below in Figure 2.  
 
Figure 2: TEM Image of core at 140,000X magnification 
 
The TEM image demonstrates the successful formulation of the dense, calcium phosphate core 
containing the peptide/DNA complex. Sizes of cores were concentrated around 20 nm. The 
hydrophobic cores were then modified with the proper outer leaflet lipids (DOTAP, polyethelene 
glycol, cholesterol and galactose) for liver targeting. The final, water soluble nanoparticles were 
observed to be roughly 40-80 nanometers in diameter as evident in Figure. The successful 
formulation of the LCP NP was also further verified by dynamic light scattering (DLS) analysis. 
For these microscopy and DLS analysis, the peptide used for conjugation was the standard, CR8C 
peptide that was previously established by Hu et al [2]. DLS analysis further confirmed particle 
size homogeneity and the absence of large aggregates, which are known to complicate successful 
delivery.  
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Figure 3: TEM image of final particle at 140,000X magnification 
Mechanism of import.  
To determine whether the nuclear pore complex, the proposed mechanism of import for 
peptide/DNA and histone/DNA conjugates, is correct, a specific inhibitor of the nuclear pore 
complex (Importazole) was used [22, 23]. Typically, cargo is bound to a substrate that contains a 
nuclear localization sequence. In the absence of Importazole (IMP), nuclear localization 
sequences, the primary method of import through nuclear pore complexes, binds to beta-importin. 
Upon binding, RanGTP subsequently triggers release of cargo from the substrate nuclear 
localization sequence into the nucleus [24]. Importazole is a specific inhibitor of the nuclear pore 
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complex that interrupts the binding of RanGTP with beta-importin. In the presence of IMP, the 
cargo/substrate complex binds to beta-importin as usual. However, RanGTP’s inability to associate 
with beta-importin prevents cargo from being released into the cell nucleus. As a result, cargos are 
concentrated around the nuclear membrane, but do not enter cell nuclei. The structure and 
mechanism of Importazole is shown below in Figure 4.  
 
Figure 4: Structure and mechanism of Importazole, a nuclear pore specific inhibitor. The two 
circled groups represent the binding domains between Importazole and beta importin. 
 
By treating HUH7 liver hepatocytes with IMP and determining the efficacy of nuclear import with, 
and without IMP, the necessity of the nuclear pore complex on DNA import was determined. The 
previous study conducted by Hu et al. uses monocyclic CR8C as the delivery peptide. Therefore, 
all peptides in this study were compared to CR8C to determine their relative efficacy. Hu et al. 
also proposed the use of histone tail H3 as a possible delivery vehicle. Therefore, the first study 
for the necessity of the nuclear pore complex compares CK8C and histone tail H3 with CR8C. By 
comparing peptides of different cationic residues (lysine vs. arginine) and also histones (H3) in 
comparison with peptides, it was determined that peptides of varying biochemical properties and 
histones both utilize the nuclear pore complex for import.   
As shown in Figure 5, the nuclear import ability for CR8C, CK8C and histone H3 were compared 
with and without Importazole. In each quadrant (A through D), four images were obtained that 
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correspond to the same field of cells. DNA conjugated to CK8C or histone H3 was displayed as 
red (cy3) while DNA conjugated to CR8C was displayed as green (cy5). Cell nuclei were stained 
with DAPI and displayed as blue. Fields A and B correspond to comparisons in the absence of 
Importazole while fields C and D correspond to comparisons in the presence of Importazole. As 
evident in Figure 5, the presence of Importazole negatively affected the import of CR8C, CK8C 
and histone H3. As consistent with the mechanism of IMP, groups which received Importazole 
treatment, Figure 5C and 5D, displayed a prominent yellow (due to the overlap of red and green 
channels) ring around the cell nuclei, but no signal within nuclei. On the other hand, groups in the 
absence of IMP, Figure 5A and 5B displayed a prominent yellow signal within the cell nuclei, co-
localized with the blue DAPI nuclear signal.  
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Figure 5: Confocal microscopy images of DNA/Peptide or DNA/Histone complexes delivered to 
living HUH7 cells at 40 X magnification. Figure 5A and 5B compare CK8C and histone H3 with 
CR8C in the absence of importazole, a nuclear pore complex inhibitor. Meanwhile, figures 5C and 
5D compare CK8C and histone H3 with CR8C in the presence of IMP. Red corresponds to the 
Cy3 DNA delivered using either CK8C (Figures 5A and 5C) or histone H3 (Figures 5B and 5D). 
Meanwhile, green corresponds to Cy5 DNA delivered using CR8C. Blue represents DAPI, a cell 
nucleus stain and yellow emerges from the overlap of red and green channels. Images were taken 
2.5 hours after addition of particles.  
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Figure 6: Quantitation of co-localization between labeled DNA signal and DAPI nuclear signal 
for various peptides tested. **P < 0.01, ***P < 0.005. Error bars represent the standard error of 
the mean (SEM). N = 5 
 
For a more definitive measure of the effect of Importazole on nuclear import, the data in Figure 5 
was quantitated to display nuclear import. Successful nuclear import was displayed as co-
localization between either red or green, corresponding to DNA delivered by select peptides and 
blue, the cell nuclei stained by DAPI. Co-localization was conducted in ImageJ using the Coloc 
2.0 analysis feature. In agreement with the images obtained from Figure 5, a statistically significant 
difference was found for all three groups in the presence and absence of Importazole. As a result, 
the information shown above in Figures 5 and 6 demonstrate that Importazole successfully 
inhibited nuclear import of DNA delivered using either CR8C, CK8C and histone H3 by 
compromising the function of the nuclear pore complex. This result suggests that various peptides 
and histones respectively all rely on the nuclear pore complex for import [25]. Therefore, the 
mechanistic basis of nuclear import was determined to be the nuclear pore complex.  
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This study, however, revealed a curious observation. It seemed that CR8C, the default peptide for 
our study, performed weaker than CK8C in terms of nuclear import. While the difference was not 
statistically significant, we sought to determine how CR8C compared to other peptides in terms of 
importing ability. Since CK8C and CR8C were of similar charge and length, we then sought to 
investigate whether the length of the peptide would affect nuclear import ability. Three peptides 
were investigated, CR8C, CR6C and CR4C in the absence of Importazole. CR8C was used as the 
standard of comparison.  
 
 
Figure 7: Investigation into peptide length and nuclear import. Confocal microscopy (40X 
magnification) images of CR6C and CR4C against CR8C along with quantitation. Red 
corresponds to the Cy3 DNA delivered using either CR6C or CR4C. Meanwhile, green 
corresponds to Cy5 DNA delivered using CR8C. Blue represents DAPI, a cell nucleus stain and 
yellow emerges from the overlap of red and green channels. Images were taken 2.5 hours after 
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addition of particles. *N.S = not significant. Error bars represent the standard error of the mean 
(SEM). N = 5 
 
As illustrated in figure 7, a kinetic study was conducted to examine the nuclear import of each 
peptide over 2.5 hours at 1 hour intervals from 0.5 hours after the addition of nanoparticles to 
HUH7 cells in vitro. Results demonstrated a time-dependent nuclear uptake of DNA delivered 
using each of the three tested peptides. Figure 7 indicates that peptide length does not have a 
statistically significant bearing on nuclear import ability. Furthermore, merged images displayed 
a large quantity of yellow signal, indicating the overlap between red (the peptide tested) and green 
(CR8C).  
 
Previously, it was assumed that shorter peptides would have difficulty wrapping around DNA for 
condensation. Furthermore, the shortest peptide, CR4C contains 4 fewer cationic arginine residues 
than CR8C. Despite the subtle differences, no significant difference was observed upon small 
differences in length and charge. Next, we sought to examine peptides that differed from the basis 
of comparison, CR8C in a more drastic measure.  
 
As no significant difference was observed in the study conducted above in Figure 7, we 
investigated three additional peptides following the same criteria as shown above: CRGC, 
C(RG)2C and C(RG)4C. These peptides were selected as they differ from the previous tested 
peptides in terms of charge, charge density and length, increasing the chance of observing a 
measurable difference between peptides.  
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Figure 8: Confocal microscopy (40X magnification) images of C(RG)C, C(RG)2C and C(RG)4C 
against CR8C along with quantitation. Red corresponds to the Cy3 DNA delivered using either 
C(RG)C, C(RG)2C and C(RG)4C. Meanwhile, green corresponds to Cy5 DNA delivered using 
CR8C. Blue represents DAPI, a cell nucleus stain and yellow emerges from the overlap of red and 
green channels. Images were taken 2.5 hours after addition of particles. *P < 0.05, **P < 0.01. 
Error bars represent the standard error of the mean (SEM). N = 5 
 
 
As illustrated in figure 8, a kinetic study was conducted to examine the nuclear import of each 
peptide over 2.5 hours at 1 hour intervals from 0.5 hours after the addition of nanoparticles to 
HUH7 cells in vitro. Results demonstrated a time-dependent nuclear uptake of DNA delivered 
using each of the four tested peptides. Again, CR8C was used as the basis of comparison for 
CRGC, C(RG)2C and C(RG)4C. A statistically significant difference in uptake was observed 
between CRGC and C(RG)2C with CR8C after 2.5 hours. This result was largely due to the 
differences in charge density between both CRGC, C(RG)2C and CR8C. Since DNA must be 
bound to peptide in order to traffic into the nucleus, it can be assumed that nuclear import is also 
a function of DNA/peptide affinity.  
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Previous dogma suggested that the major factor dictating the import of DNA using a peptide 
nuclear localization signal was the charge of the peptide. As DNA is anionic, it was believed that 
the more cationic a peptide, the greater affinity it would have for DNA and a subsequent increase 
in nuclear import would be observed However, the results in Figure 8 contradict this assumption. 
All three of the tested peptides, CRGC, C(RG)2C and C(RG)4C, are less cationic than CR8C with 
at least 4 fewer cationic arginine residues. Yet, two of the three peptides displayed an increased 
nuclear uptake over CR8C. Rather than looking at charge alone, charge density played the primary 
role in nuclear import.  
 
In light of this observation, one critical distinction was discovered.  The efficacy of DNA import 
is a measure of both DNA binding, and release from the peptide. If DNA is bound too tightly, and 
cannot release, the peptide/DNA complex will localize at the inner nuclear membrane. However, 
the DNA will not be released into the nucleus, resulting in lower quantified import. Therefore, the 
quantitation obtained in figures 5 through 8 is a result of DNA firstly being bound to the delivery 
peptide, and subsequently released after import.  
 
As the peptide serves as the nuclear localization signal, the peptide must be bound tightly to the 
DNA in order for the DNA to be trafficked into the nucleus. However, on key factor dictating 
successful nuclear import is the subsequent dissociation between the nuclear localization peptide 
and the cargo, in this case DNA. DNA must not only be released for successful import, it must 
also be released in order to effect efficacy by being translated and transcribed into the protein of 
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interest. Therefore, the studies shown in figure 5 and 6 above serve to investigate both the binding 
affinity and the releasing ability of peptides in question.  
 
Figure 9: Schematic showing the properties of peptide binding and release in nuclear import. 
 
This delicate balance between binding and release is further diagramed in Figure 9. DNA must 
first be complexed with the peptide in order for formulation into LCP nanoparticles and also for 
import past the cell and nuclear membranes. However, the final step regards the dissociation 
between the peptide and DNA. Highly cationic peptides may suffer at this step as they bind too 
tightly to allow for easy cleavage between the peptide and DNA. This is reflected in deficits of 
both nuclear import, and the activity of the DNA. Up until this point, neither the dissociation nor 
the activity of DNA has been tested. Preliminary studies have been conducted to test the release 
of DNA from peptide using hyaluronic acid (HA). HA was added to mixtures of peptide, DNA 
and SYBR green and the florescence was monitored over time. Peptides that bind stronger would 
have trouble dissociating from DNA, resulting in a lower signal than peptides that bind weaker. 
However, a prominent background effect was observed between SYBR green and HA even in the 
absence of DNA. Therefore, other methods of measuring the dissociation between peptide and 
DNA are currently undergoing. One hypothesis regards the use of nitrocellulose filter binding. 
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While the dissociation of DNA and peptide has yet to be quantified, the activity of released DNA 
has been observed and tested in vivo. Since DNA must be dissociated from peptides in order to 
effect activity, the dissociation of DNA can be indirectly quantified through the in vivo activity. 
 
In Vivo Testing of DNA Activity 
 
To determine the in vivo activity of DNA delivered using LCP nanoparticles, BALB/c mice were 
given a single, intravenous administration of LCP NP containing 40 ug of RFP-DNA condensed 
with either CR8C, CK8C or C(RG)4C. These peptides were chosen to eliminate any confounding 
factors regarding the length of the peptides. While previous studies in figure 7 dismiss any length 
dependence, on dissociation or release, the use of these three peptides ensures minimalized 
confounding factors. The RFP-DNA used herein is not, by itself, florescent. Rather, the plasmid 
encodes the RFP gene. In order for the florescent protein to be produced, the RFP-DNA must be 
translated and transcribed into the RFP protein. This method allows us to definitively determine 
the level of DNA activity which is delivered by the LCP platform. GFP was not used as the liver 
is known to contain a high background at the GFP emission channel.  
 
Following the administration of RFP-DNA, mice were sacrificed after 24 hours and livers were 
read for RFP via IVIS. Results and quantitation of these results are shown below in Figure 10. 
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Figure 10: Quantitation of activity using IVIS imaging. N = 3. 
 
While CR8C, CK8C and C(RG)4C performed differently during in vivo testing, it was seen that no 
statistically significant difference was obtained across all 5 tested groups. HD corresponds to mice 
that received a hydrodynamic injection of 40 ug of RFP DNA. The hydrodynamic method was 
established by Liu et al. wherein 1 mL of saline containing DNA is injected intravenously to mice 
within a span of 1-3 seconds [26]. While the method lacks clinical relevance for obvious reasons, 
the hydrodynamic method allows for rapid and substantial gene delivery to liver tissues [27-30]. 
For animal experimentation of gene delivery, the hydrodynamic model is often used as a positive 
control to ensure the activity of the DNA. Herein, it was observed that the highest signal arose 
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from the hydrodynamic group, indicating that the DNA was in fact, active. However, no 
statistically significant difference was observed across the tested peptide groups. Off target effects 
were observed in the kidney for all groups with a high quantity of additional lung uptake in 
hydrodynamic injected mice as shown in Figure 11.  
 
Figure 11: RFP Imaging of liver, lung and kidney from each group. Spleen tissue was also 
extracted and imaged but no quantifiable signal was observed. Therefore, spleen data has been 
omitted from this panel.  
 
High levels of lung uptake are not expected with the hydrodynamic injected group. However, the 
abnormally high lung uptake in Figure 11 may be attributed to the perfusion of mice prior to organ 
dissection. Since the hydrodynamic method introduces a large volume (nearly doubling the mouse 
blood volume), in a short amount of time. Slight tissue edema may occur. While this would not 
typically result in high off target uptake, the further use of perfusion may have inadvertently 
washed active RFP protein transcribed in the liver to other organs. Due to the organ’s increased 
permeability from swelling after hydrodynamic injection, unwanted localization of protein into 
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other organs may have occurred during perfusion. Perfusion would not adversely affect other 
groups as no hydrodynamic induced edema may have permeabilized tissues [28]. Therefore, the 
future studies along this direction should not use perfusion techniques for hydrodynamic injected 
mice. The use of perfusion may have also inadvertently lowered the level of RFP protein in the 
liver. As indicated in Figure 11, the level of RFP in the hydrodynamic injected liver is not 
significant higher than that of C(RG)4C and CK8C. The actual level of RFP transcribed by the 
liver of the hydrodynamic group is likely far larger than quantified, but scattered across different 
organs. Future studies can also test whether mice can be imaged for RFP expression without 
requiring organ extraction. Mice can be sedated using Isoflurane and imaged while alive, allowing 
for kinetic studies without the complicating factor of perfusion.  
 
IVIS imaging is a powerful tool for examining the organ wide distribution of RFP-DNA signal 
[31]. To investigate on a cellular basis however, liver tissue from each mouse was prepared into 
frozen sections and examined by florescent microscopy. Cell nuclei were stained with DAPI while 
RFP-DNA is easily observed on florescence microscopy in the RFP channel. The data obtained 
using this method is similar to the data which was observed in Figures 5 through 8. However, while 
previous confocal images only required the import of DNA to result in co-localization between 
cell nuclei florescence and therapeutic DNA florescence, frozen section quantifications are herein, 
different. Cy5 and Cy3 labels fluorescently label the DNA, allowing one to examine the import 
and location of DNA. On the other hand, RFP-DNA is not florescent in it of itself. Rather, RFP-
DNA must be translated into RFP protein. Quantitation of RFP therefore quantifies protein 
expression, not DNA. This measure of activity is distinctly different from the previous measures 
of import. Furthermore, since proteins are not translated in the nucleus, RFP expression should be 
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observed on an entire-cell basis rather than solely a nuclear basis. Images and quantitation are 
shown below in Figure 12.  
 
Figure 12: Florescent microscopy of liver tissue (10X magnification). Blue corresponds to cell 
nuclei stained by DAPI. Red corresponds to RFP protein. Violet/purple colors are the result of 
overlap between blue and red channels.  
 
Quantitation in Figure 12 was determined through both RFP expression and the number of cells. 
The percentage indicates the quotient between the percent of the field that is RFP positive and the 
percent of the field that is DAPI positive. This method allows for normalization as the low 
magnification inadvertently results in portions of images where cells are not present. Should the 
percent of the field that is RFP positive be used as the sole measure, images with more cells would 
show a disproportionately high level of RFP expression due solely to the number of cells. The 
quantitation in Figure 12 is further indicated in Figure 13 shown below.  
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Figure 13: Quantitation of frozen section florescent imaging depicted in Figure 13. **P < 0.01. N 
= 9. Error bars represent one SEM. 
 
As evident from figure 13, the hydrodynamic group demonstrates a statistically significant increase 
in RFP expression was observed. Furthermore, the DNA delivered using peptide C(RG)4C 
displayed a significant increase in RFP expression over the current standard, CR8C. Meanwhile, 
all treatment groups were significantly higher than the control, which received no RFP. 
 
The in vivo study revealed identified C(RG)4C to be the most optimal peptide for DNA delivery 
on the basis of DNA activity. Ultimately, DNA activity reflects the most important measure of 
successful delivery. While previous measures of import and binding elucidate clues on which 
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properties of peptides are beneficial or detrimental, the end goal of all DNA based therapy is 
efficient translation of the target protein. The success of C(RG)4C demonstrates that the previous 
notion of relying solely on peptide binding is incorrect. Therefore, this result further confirms the 
notion that the delivery of DNA using select peptides depends heavily on the balance between 
tight binding for delivery, and efficient release for transfection.  
 
Overall Summary  
 
Our results firstly focused on the successful formulation of LCP nanoparticles modified by Hu et 
al. The modifications made by Hu et al. were centered about optimizing the platform for DNA 
encapsulation and liver delivery. Successful nanoparticle formulation was confirmed by both TEM 
and DLS imaging.  
 
Upon formulation of LCP NPs, investigations into the mechanism of nuclear import revealed that 
the nuclear pore complex is the main pathway by which peptides and histones alike traffic 
therapeutic DNA into cell nuclei. Upon the addition of Importazole, a nuclear pore complex 
specific inhibiting molecule, marked decreases in nuclear import was observed among CK8C, 
CR8C and histone tail H3. With the nuclear pore complex being determined as the main pathway 
of nuclear import, the testing of various peptides and their effects on nuclear transport can be 
conducted and results can be attributed to the properties of the peptides, and not the possibility 
they may use different/more effective mechanisms than the standard of comparison, CR8C. The 
three modalities tested against importazole herein, CR8C, CK8C and histone H3 were chosen due 
to their differences, namely in the identity and charge of the cationic peptide (argenine vs. lysine) 
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and also an entirely different molecule, histone H3. Yet, the mechanism of import was still 
conserved herein across all three peptides.  
 
Upon determination of the mechanism of nuclear import, the effect of peptide length was 
investigated. By testing CR8C, CR6C and CR4C, the peptide charge was also tested inadvertently. 
As each peptide differs in the number of cationic arginine residues, it was hypothesized that the 
shorter peptides would have more difficult condensing DNA due to their shorter length and lower 
cationic charge. However, data shown in Figure 7 confirmed no statistically significant difference 
between CR6C and CR4C against CR8C, which was used as the standard of comparison herein. 
Suspiciously, the peptide charge did not affect the efficacy of nuclear import as was previously 
hypothesized.  
 
Subsequently, the effect of peptide charge density was investigated. A comparison against CR8C, 
C(RG)4C, C(RG)2C and CRGC revealed statistically significant differences between C(RG)2C and 
CRGC against CR8C after 2.5 hours. This difference reveals that peptide charge density does 
indeed affect the efficacy of nuclear import. It was deduced that charge density affects nuclear 
import as it eases the possibility of release. If the DNA cannot be released from the delivery 
peptide, it will remain conjugated on the inside of the nuclear membrane. However, peptides with 
lower charge density (and therefore more spacing between charged residues) were found to be 
more effective in terms of release.  
 
An in vivo model was then used to determine the activity of DNA released from the selected 
peptide. When CR8C, CK8C and C(RG)4C were compared, in vivo activity was highest with the 
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DNA delivered using C(RG)4C. Therefore, in vivo testing paralleled data obtained using confocal 
microscopy. Namely, the charge density of the peptide was the largest predictor of nuclear import 
and activity. This finding demonstrates that the successful delivery of therapeutic peptides using a 
nuclear localization peptide relies most heavily on the binding of DNA with peptide, and sufficient 
release from peptide once the cargo has entered the nucleus. Highly cationic peptides such as 
CK8C and CR8C demonstrate lower activity and import, which is likely due to the inability of 
DNA to release from peptides that are such highly charged. Meanwhile, C(RG)4C offers a balance 
between both binding and release, and therefore demonstrated the greatest import and activity.  
 
Through in vitro analysis of nuclear import using confocal microscopy, alongside an in vivo testing 
of DNA activity, it was observed that the charge density of delivery peptides is the best predictor 
of activity. By balancing association and dissociation between peptide/DNA complexes, peptides 
which offer single residue spacing between cationic residues, such as in the case of C(RG)4C, offer 
the most efficacious delivery. Future studies using the LCP platform for therapeutic DNA delivery 
should use C(RG)4C in place of the existing CR8C peptide for optimal activity of therapeutic 
DNA.  
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